JHCP
Jackson Hole Capital Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $78K | Sell |
940
-900
| -49% | -$74.6K | 0.01% | 229 |
|
2025
Q1 | $149K | Hold |
1,840
| – | – | 0.03% | 204 |
|
2024
Q4 | $166K | Hold |
1,840
| – | – | 0.03% | 203 |
|
2024
Q3 | $182K | Hold |
1,840
| – | – | 0.04% | 194 |
|
2024
Q2 | $171K | Hold |
1,840
| – | – | 0.04% | 195 |
|
2024
Q1 | $175K | Hold |
1,840
| – | – | 0.04% | 196 |
|
2023
Q4 | $164K | Hold |
1,840
| – | – | 0.04% | 194 |
|
2023
Q3 | $134K | Hold |
1,840
| – | – | 0.04% | 191 |
|
2023
Q2 | $153K | Hold |
1,840
| – | – | 0.04% | 199 |
|
2023
Q1 | $140K | Hold |
1,840
| – | – | 0.04% | 220 |
|
2022
Q4 | $153K | Hold |
1,840
| – | – | 0.05% | 188 |
|
2022
Q3 | $146K | Hold |
1,840
| – | – | 0.04% | 184 |
|
2022
Q2 | $137K | Buy |
1,840
+400
| +28% | +$29.8K | 0.04% | 178 |
|
2022
Q1 | $129K | Hold |
1,440
| – | – | 0.04% | 183 |
|
2021
Q4 | $161K | Hold |
1,440
| – | – | 0.05% | 172 |
|
2021
Q3 | $181K | Hold |
1,440
| – | – | 0.06% | 177 |
|
2021
Q2 | $195K | Hold |
1,440
| – | – | 0.07% | 170 |
|
2021
Q1 | $195K | Hold |
1,440
| – | – | 0.08% | 160 |
|
2020
Q4 | $203K | Hold |
1,440
| – | – | 0.09% | 140 |
|
2020
Q3 | $160K | Hold |
1,440
| – | – | 0.08% | 128 |
|
2020
Q2 | $161K | Hold |
1,440
| – | – | 0.1% | 120 |
|
2020
Q1 | $112K | Buy |
1,440
+150
| +12% | +$11.7K | 0.08% | 114 |
|
2019
Q4 | $123K | Hold |
1,290
| – | – | 0.07% | 147 |
|
2019
Q3 | $98K | Hold |
1,290
| – | – | 0.06% | 149 |
|
2019
Q2 | $113K | Hold |
1,290
| – | – | 0.07% | 144 |
|
2019
Q1 | $117K | Buy |
1,290
+90
| +8% | +$8.16K | 0.1% | 122 |
|
2018
Q4 | $86K | Buy |
+1,200
| New | +$86K | 0.09% | 116 |
|